Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Bilbo Patrick Create: Alert

All | News | Filings
Date FiledTypeDescription
04/04/2023 4 Bilbo Patrick (COO) has filed a Form 4 on Organogenesis Holdings Inc.
Txns: Paid exercise price by delivering 2,678 shares @ $2.13, valued at $5.7k
02/24/2023 4 Bilbo Patrick (COO) has filed a Form 4 on Organogenesis Holdings Inc.
Txns: Granted 327,386 shares @ $0
Granted 388,654 options to buy @ $2.51, valued at $975.5k
04/05/2022 4 Bilbo Patrick (COO) has filed a Form 4 on Organogenesis Holdings Inc.
Txns: Paid exercise price by delivering 2,497 shares @ $7.89, valued at $19.7k
02/17/2022 4 Bilbo Patrick (COO) has filed a Form 4 on Organogenesis Holdings Inc.
Txns: Granted 52,926 shares @ $0
Paid exercise price by delivering 937 shares @ $7.78, valued at $7.3k
Granted 125,522 options to buy @ $8.03, valued at $1M
11/12/2021 4 Bilbo Patrick (COO) has filed a Form 4 on Organogenesis Holdings Inc.
Txns: Exercised 30,450 options to buy @ $1.44, valued at $43.8k
04/05/2021 4 Bilbo Patrick (COO) has filed a Form 4 on Organogenesis Holdings Inc.
Txns: Paid exercise price by delivering 2,497 shares @ $19.83, valued at $49.5k
02/18/2021 4 Bilbo Patrick (COO) has filed a Form 4 on Organogenesis Holdings Inc.
Txns: Granted 10,782 shares @ $0
Granted 82,556 options to buy @ $13.68, valued at $1.1M
04/24/2020 4 Bilbo Patrick (COO) has filed a Form 4 on Organogenesis Holdings Inc.
Txns: Granted 34,035 shares @ $0
Granted 224,185 options to buy @ $4.04, valued at $905.7k
12/12/2018 4 Bilbo Patrick (COO) has filed a Form 4 on Organogenesis Holdings Inc.
Txns: Granted 121,800 shares @ $0
Granted 30,450 options to buy @ $1.44, valued at $43.8k
Granted 152,250 options to buy @ $1.18, valued at $179.7k
Granted 142,100 options to buy @ $3.46, valued at $491.7k
Granted 101,500 options to buy @ $3.46, valued at $351.2k
12/12/2018 3 Bilbo Patrick (COO) has filed a Form 3 on Organogenesis Holdings Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy